Prostaglandin E2 alters Wnt-dependent migration and proliferation in neuroectodermal stem cells: Implications for autism spectrum disorders

Cell Communication and Signaling

Volumn 12, Issue 1, 2014, Pages

  Wong, Christine T ^a   Ahmad, Eizaaz ^b   Li, Hongyan ^a   Crawford, Dorota A ^a,b  

^a YORK UNIVERSITY   (Canada)

^b York University   (Canada)

Author keywords

Autism; Cell motility; Neuroectodermal stem cells; Proliferation; Prostaglandin E2; Wnt signalling

Indexed keywords

BETA CATENIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIN D1; GELATINASE B; PHOSPHATIDYLINOSITOL 3 KINASE; PROSTAGLANDIN E RECEPTOR 1; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E RECEPTOR 3; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E2; CATNB PROTEIN, MOUSE; CCND1 PROTEIN, MOUSE; CYCLOOXYGENASE 2; MMP9 PROTEIN, MOUSE; PTGS2 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; AUTISM; BETA CATENIN GENE; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; CYCLIN D1 GENE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; MATRIX METALLOPROTEINASE 9 GENE; MOLECULAR INTERACTION; MOUSE; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN ENDOPEROXIDE SYNTHASE 2 GENE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; UPREGULATION; WNT SIGNALING PATHWAY; ANIMAL; CELL LINE; CELL MOTION; CYTOLOGY; DRUG EFFECT; GENETICS; METABOLISM; NEUROECTODERM;

ANIMALS; BETA CATENIN; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CYCLIN D1; CYCLOOXYGENASE 2; DINOPROSTONE; MATRIX METALLOPROTEINASE 9; MICE; NEURAL PLATE; NEURAL STEM CELLS; WNT SIGNALING PATHWAY;

EID: 84898482309     PISSN: None     EISSN: 1478811X     Source Type: Journal    
DOI: 10.1186/1478-811X-12-19     Document Type: Article

References (131)

1. Prostanoid receptors: subtypes and signaling. Breyer RM, Bagdassarian CK, Myers SA, Breyer MD, Annu Rev Pharmacol Toxicol 2001 41 661 690 10.1146/annurev.pharmtox.41.1.661 11264472 (Pubitemid 32385902)
2. Epidemiologic studies of exposure to prenatal infection and risk of schizophrenia and autism. Brown AS, Dev Neurobiol 2012 72 10 1272 1276 10.1002/dneu.22024 22488761
3. Maternal immune activation and autism spectrum disorder: interleukin-6 signaling as a key mechanistic pathway. Parker-Athill EC, Tan J, Neurosignals 2010 18 2 113 128 10.1159/000319828 20924155
4. Maternal infection and immune involvement in autism. Patterson PH, Trends Mol Med 2011 17 7 389 394 10.1016/j.molmed.2011.03.001 21482187
5. Developmental neurotoxicity of industrial chemicals. Grandjean P, Landrigan PJ, Lancet 2006 368 9553 2167 2178 10.1016/S0140-6736(06)69665-7 17174709 (Pubitemid 44894541)
6. The teratology of autism. Arndt TL, Stodgell CJ, Rodier PM, Int J Dev Neurosci 2005 23 2-3 189 199 15749245 (Pubitemid 40313552)
7. Prostaglandin E receptors. Sugimoto Y, Narumiya S, J Biol Chem 2007 282 16 11613 11617 10.1074/jbc.R600038200 17329241 (Pubitemid 47100657)
8. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Coleman RA, Smith WL, Narumiya S, Pharmacol Rev 1994 46 2 205 229 7938166 (Pubitemid 24185151)
9. Stress responses: the contribution of prostaglandin E(2) and its receptors. Furuyashiki T, Narumiya S, Nat Rev Endocrinol 2011 7 3 163 175 10.1038/nrendo.2010.194 21116297
10. Emerging roles of PGE2 receptors in models of neurological disease. Andreasson K, Prostaglandins Other Lipid Mediat 2010 91 3-4 104 112 19808012
11. Expression of enzymes involved in the synthesis of prostaglandin E2 in bovine in vitro-produced embryos. Saint-Dizier M, Guyader-Joly C, Charpigny G, Grimard B, Humblot P, Ponter AA, Zygote 2011 19 3 277 283 10.1017/ S0967199410000596 21232167
12. Prostaglandin E(2) and misoprostol induce neurite retraction in Neuro-2a cells. Tamiji J, Crawford DA, Biochem Biophys Res Commun 2010 398 3 450 456 10.1016/j.bbrc.2010.06.098 20599704
13. Endogenous PGE2 regulates membrane excitability and synaptic transmission in hippocampal CA1 pyramidal neurons. Chen C, Bazan NG, J Neurophysiol 2005 93 2 929 941 15653788
14. Prostaglandin E2 stimulates estradiol synthesis in the cerebellum postnatally with associated effects on Purkinje neuron dendritic arbor and electrophysiological properties. Dean SL, Wright CL, Hoffman JF, Wang M, Alger BE, McCarthy MM, Endocrinology 2012 153 11 5415 5427 10.1210/en.2012-1350 23054057
15. Lipid signaling: sleep, synaptic plasticity, and neuroprotection. Chen C, Bazan NG, Prostaglandins Other Lipid Mediat 2005 77 1-4 65 76 16099392 (Pubitemid 41133416)
16. Prostaglandin E type 1 receptors contribute to neuronal apoptosis after transient forebrain ischemia. Shimamura M, Zhou P, Casolla B, Qian L, Capone C, Kurinami H, Iadecola C, Anrather J, J Cereb Blood Flow Metab 2013 33 8 1207 1214 10.1038/jcbfm.2013.69 23632967
17. Prostaglandin E2-induced cell death is mediated by activation of EP2 receptors in motor neuron-like NSC-34 cells. Miyagishi H, Kosuge Y, Yoneoka Y, Ozone M, Endo M, Osada N, Ishige K, Kusama-Eguchi K, Ito Y, J Pharmacol Sci 2013 121 4 347 350 10.1254/jphs.12274SC 23514786
18. Potentiation of PGE(2)-mediated cAMP production during neuronal differentiation of human neuroblastoma SK-N-BE(2)C cells. Choi SY, Choi BH, Suh BC, Chae HD, Kim JS, Shin MJ, Kang SS, Negishi M, Kim KT, J Neurochem 2001 79 2 303 310 11677258 (Pubitemid 32988946)
19. The COX-2 inhibitors, meloxicam and nimesulide, suppress neurogenesis in the adult mouse brain. Goncalves MB, Williams EJ, Yip P, Yanez-Munoz RJ, Williams G, Doherty P, Br J Pharmacol 2010 159 5 1118 1125 10.1111/j.1476-5381. 2009.00618.x 20136845
20. Prostaglandins: mechanisms of action and regulation of production in bone. Raisz LG, Pilbeam CC, Fall PM, Osteoporos Int 1993 3 Suppl 1 136 140 8461541 (Pubitemid 23099913)
21. Induction of cyclo-oxygenase-2 mRNA by prostaglandin E2 in human prostatic carcinoma cells. Tjandrawinata RR, Dahiya R, Hughes-Fulford M, Br J Cancer 1997 75 8 1111 1118 10.1038/bjc.1997.192 9099957 (Pubitemid 27140020)
22. Prostaglandin E2 regulates pancreatic stellate cell activity via the EP4 receptor. Charo C, Holla V, Arumugam T, Hwang R, Yang P, Dubois RN, Menter DG, Logsdon CD, Ramachandran V, Pancreas 2013 42 3 467 474 10.1097/MPA. 0b013e318264d0f8 23090667
23. Transactivation of EGFR/PI3K/Akt involved in ATP-induced inflammatory protein expression and cell motility. Lin CC, Lin WN, Cheng SE, Tung WH, Wang HH, Yang CM, J Cell Physiol 2012 227 4 1628 1638 10.1002/jcp.22880 21678415
24. Prostaglandin E2 promotes wound-induced migration of intestinal subepithelial myofibroblasts via EP2, EP3, and EP4 prostanoid receptor activation. Iwanaga K, Okada M, Murata T, Hori M, Ozaki H, J Pharmacol Exp Ther 2012 340 3 604 611 10.1124/jpet.111.189845 22138372
25. Detection of prostaglandin E2-induced dendritic cell migration into the lymph nodes of mice using a 1.5 T clinical MR scanner. Joo HJ, Kim HS, Choi YS, Kim H, Kim SJ, Moon WK, NMR Biomed 2012 25 4 570 579 10.1002/nbm.1774 22009917
26. Prostaglandin E2 promotes migration and adhesion in hepatocellular carcinoma cells. Mayoral R, Fernandez-Martinez A, Bosca L, Martin-Sanz P, Carcinogenesis 2005 26 4 753 761 10.1093/carcin/bgi022 15661807 (Pubitemid 41214337)
27. Effects of prostaglandin E2 on mesangial cell migration. Jaffer S, Mattana J, Singhal PC, Am J Nephrol 1995 15 4 300 305 10.1159/000168853 7573187
28. Misoprostol elevates intracellular calcium in Neuro-2a cells via protein kinase A. Tamiji J, Crawford DA, Biochem Biophys Res Commun 2010 399 4 565 570 10.1016/j.bbrc.2010.07.112 20678471
29. The neurobiology of lipid metabolism in autism spectrum disorders. Tamiji J, Crawford DA, Neurosignals 2010 18 2 98 112 10.1159/000323189 21346377
30. Lipid mediators in plasma of autism spectrum disorders. El-Ansary A, Al-Ayadhi L, Lipids Health Dis 2012 11 160 10.1186/1476-511X-11-160 23170784
31. Prostaglandin E2 is an endogenous modulator of cerebellar development and complex behavior during a sensitive postnatal period. Dean SL, Knutson JF, Krebs-Kraft DL, McCarthy MM, Eur J Neurosci 2012 35 8 1218 1229 10.1111/j.1460-9568.2012.08032.x 22512254
32. Autism and Mobius sequence: an exploratory study of children in northeastern Brazil. Bandim JM, Ventura LO, Miller MT, Almeida HC, Costa AE, Arq Neuropsiquiatr 2003 61 2A 181 185 10.1590/S0004-282X2003000200004 12806493 (Pubitemid 36648708)
33. Autism associated with conditions characterized by developmental errors in early embryogenesis: a mini review. Miller MT, Stromland K, Ventura L, Johansson M, Bandim JM, Gillberg C, Int J Dev Neurosci 2005 23 2-3 201 219 15749246 (Pubitemid 40313553)
34. Neurological disorders. The mystery of the missing smile. Miller G, Science 2007 316 5826 826 827 10.1126/science.316.5826.826 17495152 (Pubitemid 46764258)
35. Lipid Signalling in the Pathology of Autism Spectrum Disorders. Wong C, Crawford D, Comprehensive Guide to Autism New York: Springer, Patel VB, Preedy VR, Martin CR, 2014 1259 1283
36. Mechanical induction of PGE2 in osteocytes blocks glucocorticoid-induced apoptosis through both the beta-catenin and PKA pathways. Kitase Y, Barragan L, Qing H, Kondoh S, Jiang JX, Johnson ML, Bonewald LF, J Bone Miner Res 2010 25 12 2657 2668 10.1002/jbmr.168 20578217
37. Prostaglandin E2 modulates components of the Wnt signaling system in bone and prostate cancer cells. Liu XH, Kirschenbaum A, Weinstein BM, Zaidi M, Yao S, Levine AC, Biochem Biophys Res Commun 2010 394 3 715 720 10.1016/j.bbrc.2010. 03.057 20227393
38. Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration. Goessling W, North TE, Loewer S, Lord AM, Lee S, Stoick-Cooper CL, Weidinger G, Puder M, Daley GQ, Moon RT, Zon LI, Cell 2009 136 6 1136 1147 10.1016/j.cell.2009.01.015 19303855
39. Human mesenchymal stem cell proliferation is regulated by PGE2 through differential activation of cAMP-dependent protein kinase isoforms. Kleiveland CR, Kassem M, Lea T, Exp Cell Res 2008 314 8 1831 1838 10.1016/j.yexcr.2008.02. 004 18395713
40. WNTs in the vertebrate nervous system: from patterning to neuronal connectivity. Ciani L, Salinas PC, Nat Rev Neurosci 2005 6 5 351 362 15832199 (Pubitemid 40593481)
41. Wnt signaling signaling at and above the receptor level. Buechling T, Boutros M, Curr Top Dev Biol 2011 97 21 53 22074601
42. Connecting COX-2 and Wnt in cancer. Buchanan FG, DuBois RN, Cancer Cell 2006 9 1 6 8 10.1016/j.ccr.2005.12.029 16413466 (Pubitemid 43069505)
43. A small-molecule agonist of the Wnt signaling pathway. Liu J, Wu X, Mitchell B, Kintner C, Ding S, Schultz PG, Angew Chem Int Ed Engl 2005 44 13 1987 1990 10.1002/anie.200462552 15724259 (Pubitemid 40483016)
44. Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Castellone MD, Teramoto H, Williams BO, Druey KM, Gutkind JS, Science 2005 310 5753 1504 1510 10.1126/science.1116221 16293724 (Pubitemid 41746348)
45. Phosphorylation of glycogen synthase kinase-3 and stimulation of T-cell factor signaling following activation of EP2 and EP4 prostanoid receptors by prostaglandin E2. Fujino H, West KA, Regan JW, J Biol Chem 2002 277 4 2614 2619 10.1074/jbc.M109440200 11706038 (Pubitemid 34953286)
46. Prostaglandin E2 increases growth and motility of colorectal carcinoma cells. Sheng H, Shao J, Washington MK, DuBois RN, J Biol Chem 2001 276 21 18075 18081 10.1074/jbc.M009689200 11278548
47. Identification of a novel phosphorylation site on histone H3 coupled with mitotic chromosome condensation. Goto H, Tomono Y, Ajiro K, Kosako H, Fujita M, Sakurai M, Okawa K, Iwamatsu A, Okigaki T, Takahashi T, Inagaki M, J Biol Chem 1999 274 36 25543 25549 10.1074/jbc.274.36.25543 10464286 (Pubitemid 29418579)
48. Phosphorylation of histone H3 Ser10 establishes a hierarchy for subsequent intramolecular modification events. Liokatis S, Stutzer A, Elsasser SJ, Theillet FX, Klingberg R, van Rossum B, Schwarzer D, Allis CD, Fischle W, Selenko P, Nat Struct Mol Biol 2012 19 8 819 823 10.1038/nsmb.2310 22796964
49. Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation. Nowak SJ, Corces VG, Trends Genet 2004 20 4 214 220 15041176 (Pubitemid 38369193)
50. Wnt signaling: a common theme in animal development. Cadigan KM, Nusse R, Genes Dev 1997 11 24 3286 3305 10.1101/gad.11.24.3286 9407023 (Pubitemid 28023954)
51. Threonine 41 in beta-catenin serves as a key phosphorylation relay residue in beta-catenin degradation. Wu G, He X, Biochemistry 2006 45 16 5319 5323 10.1021/bi0601149 16618120
52. Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity. Fang D, Hawke D, Zheng Y, Xia Y, Meisenhelder J, Nika H, Mills GB, Kobayashi R, Hunter T, Lu Z, J Biol Chem 2007 282 15 11221 11229 10.1074/jbc.M611871200 17287208 (Pubitemid 47100795)
53. PTEN-deficient intestinal stem cells initiate intestinal polyposis. He XC, Yin T, Grindley JC, Tian Q, Sato T, Tao WA, Dirisina R, Porter-Westpfahl KS, Hembree M, Johnson T, Wiedemann LM, Barrett TA, Hood L, Wu H, Li L, Nat Genet 2007 39 2 189 198 10.1038/ng1928 17237784 (Pubitemid 46184349)
54. Differential regulation of airway smooth muscle cell migration by E-prostanoid receptor subtypes. Aso H, Ito S, Mori A, Suganuma N, Morioka M, Takahara N, Kondo M, Hasegawa Y, Am J Respir Cell Mol Biol 2013 48 3 322 329 10.1165/rcmb.2012-0158OC 23221043
55. Focal adhesion kinase: important to prostaglandin E2-mediated adhesion, migration and invasion in hepatocellular carcinoma cells. Bai XM, Zhang W, Liu NB, Jiang H, Lou KX, Peng T, Ma J, Zhang L, Zhang H, Leng J, Oncol Rep 2009 21 1 129 136 19082453
56. PGE2-induced metalloproteinase-9 is essential for dendritic cell migration. Yen JH, Khayrullina T, Ganea D, Blood 2008 111 1 260 270 10.1182/blood-2007-05-090613 17925490
57. The role of PGE2-associated inflammatory responses in gastric cancer development. Oshima H, Oshima M, Semin Immunopathol 2013 35 2 139 150 10.1007/s00281-012-0353-5 23053397
58. Prostaglandin E2 Stimulates the beta-catenin/T cell factor-dependent transcription in colon cancer. Shao J, Jung C, Liu C, Sheng H, J Biol Chem 2005 280 28 26565 26572 10.1074/jbc.M413056200 15899904 (Pubitemid 41022254)
59. PGE2-regulated wnt signaling and N-acetylcysteine are synergistically hepatoprotective in zebrafish acetaminophen injury. North TE, Babu IR, Vedder LM, Lord AM, Wishnok JS, Tannenbaum SR, Zon LI, Goessling W, Proc Natl Acad Sci U S A 2010 107 40 17315 17320 10.1073/pnas.1008209107 20855591
60. LGR5 promotes survival in human colorectal adenoma cells and is upregulated by PGE2: implications for targeting adenoma stem cells with NSAIDs. Al-Kharusi MR, Smartt HJ, Greenhough A, Collard TJ, Emery ED, Williams AC, Paraskeva C, Carcinogenesis 2013 34 5 1150 1157 10.1093/carcin/bgt020 23349017
61. The basics of brain development. Stiles J, Jernigan TL, Neuropsychol Rev 2010 20 4 327 348 10.1007/s11065-010-9148-4 21042938
62. Integrative mechanisms of oriented neuronal migration in the developing brain. Evsyukova I, Plestant C, Anton ES, Annu Rev Cell Dev Biol 2013 29 299 353 10.1146/annurev-cellbio-101512-122400 23937349
63. Central nervous system neuronal migration. Hatten ME, Annu Rev Neurosci 1999 22 511 539 10.1146/annurev.neuro.22.1.511 10202547 (Pubitemid 29144896)
64. Wnt signaling: multiple functions in neural development. Ille F, Sommer L, Cell Mol Life Sci 2005 62 10 1100 1108 10.1007/s00018-005-4552-2 15928805 (Pubitemid 40868528)
65. Wnt signalling in mouse gastrulation and anterior development: new players in the pathway and signal output. Arkell RM, Fossat N, Tam PP, Curr Opin Genet Dev 2013 23 4 454 460 10.1016/j.gde.2013.03.001 23608663
66. Mammalian Ryk is a Wnt coreceptor required for stimulation of neurite outgrowth. Lu W, Yamamoto V, Ortega B, Baltimore D, Cell 2004 119 1 97 108 10.1016/j.cell.2004.09.019 15454084 (Pubitemid 39349323)
67. Frizzled/RYK mediated signalling in axon guidance. Bovolenta P, Rodriguez J, Esteve P, Development 2006 133 22 4399 4408 10.1242/dev.02592 17035295 (Pubitemid 46017814)
68. Anterior-posterior guidance of commissural axons by Wnt-frizzled signaling. Lyuksyutova AI, Lu CC, Milanesio N, King LA, Guo N, Wang Y, Nathans J, Tessier-Lavigne M, Zou Y, Science 2003 302 5652 1984 1988 10.1126/science.1089610 14671310 (Pubitemid 37523510)
69. Wnt signaling in axon guidance. Zou Y, Trends Neurosci 2004 27 9 528 532 10.1016/j.tins.2004.06.015 15331234 (Pubitemid 39149821)
70. Morphogens as growth cone signalling molecules. Sanchez-Camacho C, Rodriguez J, Ruiz JM, Trousse F, Bovolenta P, Brain Res Brain Res Rev 2005 49 2 242 252 10.1016/j.brainresrev.2004.10.004 16111553 (Pubitemid 41160393)
71. Wnt signaling through Dishevelled, Rac and JNK regulates dendritic development. Rosso SB, Sussman D, Wynshaw-Boris A, Salinas PC, Nat Neurosci 2005 8 1 34 42 10.1038/nn1374 15608632 (Pubitemid 41236729)
72. Activity-dependent dendritic arborization mediated by CaM-kinase I activation and enhanced CREB-dependent transcription of Wnt-2. Wayman GA, Impey S, Marks D, Saneyoshi T, Grant WF, Derkach V, Soderling TR, Neuron 2006 50 6 897 909 10.1016/j.neuron.2006.05.008 16772171 (Pubitemid 43850689)
73. Wnt signaling mutants have decreased dentate granule cell production and radial glial scaffolding abnormalities. Zhou CJ, Zhao C, Pleasure SJ, J Neurosci 2004 24 1 121 126 10.1523/JNEUROSCI.4071-03.2004 14715945 (Pubitemid 38181677)
74. Activity-dependent synaptic Wnt release regulates hippocampal long term potentiation. Chen J, Park CS, Tang SJ, J Biol Chem 2006 281 17 11910 11916 10.1074/jbc.M511920200 16501258 (Pubitemid 43855453)
75. Wnt signaling mediates experience-related regulation of synapse numbers and mossy fiber connectivities in the adult hippocampus. Gogolla N, Galimberti I, Deguchi Y, Caroni P, Neuron 2009 62 4 510 525 10.1016/j.neuron.2009.04.022 19477153
76. A Wnt1-regulated genetic network controls the identity and fate of midbrain-dopaminergic progenitors in vivo. Prakash N, Brodski C, Naserke T, Puelles E, Gogoi R, Hall A, Panhuysen M, Echevarria D, Sussel L, Weisenhorn DM, Martinez S, Arenas E, Simeone A, Wurst W, Development 2006 133 1 89 98 10.1242/dev.02181 16339193 (Pubitemid 43169323)
77. Stage-dependent fate determination of neural precursor cells in mouse forebrain. Hirabayashi Y, Gotoh Y, Neurosci Res 2005 51 4 331 336 10.1016/j.neures.2005.01.004 15740796 (Pubitemid 40299321)
78. Neuronal production and precursor proliferation defects in the neocortex of mice with loss of function in the canonical Wnt signaling pathway. Zhou CJ, Borello U, Rubenstein JL, Pleasure SJ, Neuroscience 2006 142 4 1119 1131 10.1016/j.neuroscience.2006.07.007 16920270 (Pubitemid 44642330)
79. Defining the impact of beta-catenin/Tcf transactivation on epithelial stem cells. Lowry WE, Blanpain C, Nowak JA, Guasch G, Lewis L, Fuchs E, Genes Dev 2005 19 13 1596 1611 10.1101/gad.1324905 15961525 (Pubitemid 41003002)
80. Regulation of cerebral cortical size by control of cell cycle exit in neural precursors. Chenn A, Walsh CA, Science 2002 297 5580 365 369 10.1126/science.1074192 12130776 (Pubitemid 34790759)
81. A local Wnt-3a signal is required for development of the mammalian hippocampus. Lee SM, Tole S, Grove E, McMahon AP, Development 2000 127 3 457 467 10631167 (Pubitemid 30093394)
82. A review of the evidence for the canonical Wnt pathway in autism spectrum disorders. Kalkman HO, Mol Autism 2012 3 1 10 10.1186/2040-2392-3-10 23083465
83. Synaptic Wnt signaling-a contributor to major psychiatric disorders? Okerlund ND, Cheyette BN, J Neurodev Disord 2011 3 2 162 174 10.1007/s11689-011-9083-6 21533542
84. Abnormalities of Wnt signalling in schizophrenia - evidence for neurodevelopmental abnormality. Cotter D, Kerwin R, Al-Sarraji S, Brion JP, Chadwich A, Lovestone S, Anderton B, Everall I, Neuroreport 1998 9 7 1379 1383 10.1097/00001756-199805110-00024 9631433 (Pubitemid 28264255)
85. The WNT2 gene polymorphism associated with speech delay inherent to autism. Lin PI, Chien YL, Wu YY, Chen CH, Gau SS, Huang YS, Liu SK, Tsai WC, Chiu YN, Res Dev Disabil 2012 33 5 1533 1540 10.1016/j.ridd.2012.03.004 22522212
86. Evidence supporting WNT2 as an autism susceptibility gene. Wassink TH, Piven J, Vieland VJ, Huang J, Swiderski RE, Pietila J, Braun T, Beck G, Folstein SE, Haines JL, Sheffield VC, Am J Med Genet 2001 105 5 406 413 10.1002/ajmg.1401 11449391 (Pubitemid 32601590)
87. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Liu C, Li Y, Semenov M, Han C, Baeg GH, Tan Y, Zhang Z, Lin X, He X, Cell 2002 108 6 837 847 10.1016/S0092-8674(02)00685-2 11955436 (Pubitemid 34327534)
88. Beta-catenin destruction complex: insights and questions from a structural perspective. Kimelman D, Xu W, Oncogene 2006 25 57 7482 7491 10.1038/sj.onc.1210055 17143292 (Pubitemid 44885747)
89. Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase. Taurin S, Sandbo N, Qin Y, Browning D, Dulin NO, J Biol Chem 2006 281 15 9971 9976 10.1074/jbc.M508778200 16476742 (Pubitemid 43864529)
90. AMP-activated protein kinase (AMPK) cross-talks with canonical Wnt signaling via phosphorylation of beta-catenin at Ser 552. Zhao J, Yue W, Zhu MJ, Sreejayan N, Du M, Biochem Biophys Res Commun 2010 395 1 146 151 10.1016/j.bbrc.2010.03.161 20361929
91. Induction of Gsk3beta-beta-TrCP Interaction Is Required for Late Phase Stabilization of beta-catenin in Canonical Wnt Signaling. Gao C, Chen G, Romero G, Moschos S, Xu X, Hu J, J Biol Chem 2014 Epub ahead of print
92. Neuron number and size in prefrontal cortex of children with autism. Courchesne E, Mouton PR, Calhoun ME, Semendeferi K, Ahrens-Barbeau C, Hallet MJ, Barnes CC, Pierce K, JAMA 2011 306 18 2001 2010 10.1001/jama.2011.1638 22068992
93. Age-dependent brain gene expression and copy number anomalies in autism suggest distinct pathological processes at young versus mature ages. Chow ML, Pramparo T, Winn ME, Barnes CC, Li HR, Weiss L, Fan JB, Murray S, April C, Belinson H, Fu XD, Wynshaw-Boris A, Schork NJ, Courchesne E, PLoS Genet 2012 8 3 1002592 10.1371/journal.pgen.1002592 22457638
94. A de novo convergence of autism genetics and molecular neuroscience. Krumm N, O'Roak BJ, Shendure J, Eichler EE, Trends Neurosci 2014 37 2 95 105 10.1016/j.tins.2013.11.005 24387789
95. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. O'Roak BJ, Vives L, Girirajan S, Karakoc E, Krumm N, Coe BP, Levy R, Ko A, Lee C, Smith JD, Turner EH, Stanaway IB, Vernot B, Malig M, Baker C, Reilly B, Akey JM, Borenstein E, Rieder MJ, Nickerson DA, Bernier R, Shendure J, Eichler EE, Nature 2012 485 7397 246 250 10.1038/nature10989 22495309
96. Wnt/beta-catenin signaling enhances cyclooxygenase-2 (COX2) transcriptional activity in gastric cancer cells. Nunez F, Bravo S, Cruzat F, Montecino M, De Ferrari GV, PLoS One 2011 6 4 18562 10.1371/journal.pone.0018562 21494638
97. Transcriptional regulation of the cyclin D1 gene at a glance. Klein EA, Assoian RK, J Cell Sci 2008 121 Pt 23 3853 3857 19020303
98. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, Ben-Ze'ev A, Proc Natl Acad Sci U S A 1999 96 10 5522 5527 10.1073/pnas.96.10.5522 10318916 (Pubitemid 29234650)
99. Matrix metalloproteinase (MMP)-9 induced by Wnt signaling increases the proliferation and migration of embryonic neural stem cells at low O2 levels. Ingraham CA, Park GC, Makarenkova HP, Crossin KL, J Biol Chem 2011 286 20 17649 17657 10.1074/jbc.M111.229427 21460212
100. Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration. Wu B, Crampton SP, Hughes CC, Immunity 2007 26 2 227 239 10.1016/j.immuni.2006.12.007 17306568 (Pubitemid 46329437)
101. COX-2's new role in inflammation. Chen C, Nat Chem Biol 2010 6 6 401 402 10.1038/nchembio.375 20479749
102. Role of inducible cyclooxygenase (COX-2) in inflammation. Seibert K, Masferrer JL, Receptor 1994 4 1 17 23 8038702
103. Association between PTGS2 polymorphism and autism spectrum disorders in Korean trios. Yoo HJ, Cho IH, Park M, Cho E, Cho SC, Kim BN, Kim JW, Kim SA, Neurosci Res 2008 62 1 66 69 10.1016/j.neures.2008.05.008 18579107
104. Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial. Asadabadi M, Mohammadi MR, Ghanizadeh A, Modabbernia A, Ashrafi M, Hassanzadeh E, Forghani S, Akhondzadeh S, Psychopharmacology (Berl) 2013 225 1 51 59 10.1007/s00213-012-2796-8 22782459
105. Multiple levels of cyclin specificity in cell-cycle control. Bloom J, Cross FR, Nat Rev Mol Cell Biol 2007 8 2 149 160 10.1038/nrm2105 17245415 (Pubitemid 46432532)
106. Cdks, cyclins and CKIs: roles beyond cell cycle regulation. Lim S, Kaldis P, Development 2013 140 15 3079 3093 10.1242/dev.091744 23861057
107. Treadmill exercise ameliorates motor disturbance through inhibition of apoptosis in the cerebellum of valproic acid-induced autistic rat pups. Kim JE, Shin MS, Seo TB, Ji ES, Baek SS, Lee SJ, Park JK, Kim CJ, Mol Med Rep 2013 8 2 327 334 23760019
108. Disrupted ERK signaling during cortical development leads to abnormal progenitor proliferation, neuronal and network excitability and behavior, modeling human neuro-cardio-facial-cutaneous and related syndromes. Pucilowska J, Puzerey PA, Karlo JC, Galan RF, Landreth GE, J Neurosci 2012 32 25 8663 8677 10.1523/JNEUROSCI.1107-12.2012 22723706
109. Diminished dosage of 22q11 genes disrupts neurogenesis and cortical development in a mouse model of 22q11 deletion/DiGeorge syndrome. Meechan DW, Tucker ES, Maynard TM, LaMantia AS, Proc Natl Acad Sci U S A 2009 106 38 16434 16445 10.1073/pnas.0905696106 19805316
110. Matrix metalloproteinases: they're not just for matrix anymore! McCawley LJ, Matrisian LM, Curr Opin Cell Biol 2001 13 5 534 540 10.1016/S0955-0674(00) 00248-9 11544020 (Pubitemid 32817010)
111. Matrix metalloproteinases: effectors of development and normal physiology. Vu TH, Werb Z, Genes Dev 2000 14 17 2123 2133 10.1101/gad.815400 10970876
112. Neural functions of matrix metalloproteinases: plasticity, neurogenesis, and disease. Fujioka H, Dairyo Y, Yasunaga K, Emoto K, Biochem Res Int 2012 2012 789083 22567285
113. Induction of matrix metalloproteinase MMP-9 (92-kDa gelatinase) by retinoic acid in human neuroblastoma SKNBE cells: relevance to neuronal differentiation. Chambaut-Guerin AM, Herigault S, Rouet-Benzineb P, Rouher C, Lafuma C, J Neurochem 2000 74 2 508 517 10646501 (Pubitemid 30053722)
114. MMP-2 and MMP-9 increase the neurite-promoting potential of schwann cell basal laminae and are upregulated in degenerated nerve. Ferguson TA, Muir D, Mol Cell Neurosci 2000 16 2 157 167 10.1006/mcne.2000.0859 10924258 (Pubitemid 30651178)
115. Matrix metalloproteinase-9 promotes nerve growth factor-induced neurite elongation but not new sprout formation in vitro. Shubayev VI, Myers RR, J Neurosci Res 2004 77 2 229 239 10.1002/jnr.20160 15211589 (Pubitemid 38859407)
116. Matrix metalloproteinases in autism spectrum disorders. Abdallah M, Michel T, J Mol Psychiatry 2013 1 1 1 5
117. Amniotic fluid MMP-9 and neurotrophins in autism spectrum disorders: an exploratory study. Abdallah MW, Pearce BD, Larsen N, Greaves-Lord K, Norgaard-Pedersen B, Hougaard DM, Mortensen EL, Grove J, Autism Res 2012 5 6 428 433 10.1002/aur.1254 23008271
118. The Fragile X mental retardation protein regulates matrix metalloproteinase 9 mRNA at synapses. Janusz A, Milek J, Perycz M, Pacini L, Bagni C, Kaczmarek L, Dziembowska M, J Neurosci 2013 33 46 18234 18241 10.1523/JNEUROSCI.2207-13.2013 24227732
119. Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model. Bilousova TV, Dansie L, Ngo M, Aye J, Charles JR, Ethell DW, Ethell IM, J Med Genet 2009 46 2 94 102 18835858
120. Open-label add-on treatment trial of minocycline in fragile X syndrome. Paribello C, Tao L, Folino A, Berry-Kravis E, Tranfaglia M, Ethell IM, Ethell DW, BMC Neurol 2010 10 91 10.1186/1471-2377-10-91 20937127
121. TGF-beta effects on prostate cancer cell migration and invasion are mediated by PGE2 through activation of PI3K/AKT/mTOR pathway. Vo BT, Morton D Jr, Komaragiri S, Millena AC, Leath C, Khan SA, Endocrinology 2013 154 5 1768 1779 10.1210/en.2012-2074 23515290
122. A research strategy to discover the environmental causes of autism and neurodevelopmental disabilities. Landrigan PJ, Lambertini L, Birnbaum LS, Environ Health Perspect 2012 120 7 258 a260 10.1289/ehp.1104285 22543002
123. Intrinsic gray-matter connectivity of the brain in adults with autism spectrum disorder. Ecker C, Ronan L, Feng Y, Daly E, Murphy C, Ginestet CE, Brammer M, Fletcher PC, Bullmore ET, Suckling J, Baron-Cohen S, Williams S, Loth E, Consortium MRCAIMS, Murphy DG, Proc Natl Acad Sci U S A 2013 110 32 13222 13227 10.1073/pnas.1221880110 23878213
124. The neuropathology of autism: defects of neurogenesis and neuronal migration, and dysplastic changes. Wegiel J, Kuchna I, Nowicki K, Imaki H, Wegiel J, Marchi E, Ma SY, Chauhan A, Chauhan V, Bobrowicz TW, de Leon M, Louis LA, Cohen IL, London E, Brown WT, Wisniewski T, Acta Neuropathol 2010 119 6 755 770 10.1007/s00401-010-0655-4 20198484
125. Underconnectivity between voice-selective cortex and reward circuitry in children with autism. Abrams DA, Lynch CJ, Cheng KM, Phillips J, Supekar K, Ryali S, Uddin LQ, Menon V, Proc Natl Acad Sci U S A 2013 110 29 12060 12065 10.1073/pnas.1302982110 23776244
126. Comparison of white matter integrity between autism spectrum disorder subjects and typically developing individuals: a meta-analysis of diffusion tensor imaging tractography studies. Aoki Y, Abe O, Nippashi Y, Yamasue H, Mol Autism 2013 4 1 25 10.1186/2040-2392-4-25 23876131
127. Autism and abnormal development of brain connectivity. Belmonte MK, Allen G, Beckel-Mitchener A, Boulanger LM, Carper RA, Webb SJ, J Neurosci 2004 24 42 9228 9231 10.1523/JNEUROSCI.3340-04.2004 15496656 (Pubitemid 39426157)
128. The new neurobiology of autism: cortex, connectivity, and neuronal organization. Minshew NJ, Williams DL, Arch Neurol 2007 64 7 945 950 10.1001/archneur.64.7.945 17620483 (Pubitemid 47047993)
129. Development of the brainstem and cerebellum in autistic patients. Hashimoto T, Tayama M, Murakawa K, Yoshimoto T, Miyazaki M, Harada M, Kuroda Y, J Autism Dev Disord 1995 25 1 1 18 10.1007/BF02178163 7608030
130. Developmental vulnerability of synapses and circuits associated with neuropsychiatric disorders. Penzes P, Buonanno A, Passafaro M, Sala C, Sweet RA, J Neurochem 2013 126 2 165 182 10.1111/jnc.12261 23574039
131. Grey matter abnormality in autism spectrum disorder: an activation likelihood estimation meta-analysis study. Cauda F, Geda E, Sacco K, D'Agata F, Duca S, Geminiani G, Keller R, Neurol Neurosurg Psychiatry 2011 82 12 1304 1313 10.1136/jnnp.2010.239111